Recombinant human thrombomodulin attenuated sepsis severity in a non-surgical preterm mouse model
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recombinant human thrombomodulin attenuated sepsis severity in a non-surgical preterm mouse model
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-15
DOI
10.1038/s41598-019-57265-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Eicosapentaenoic Acid-Enriched High-Density Lipoproteins Exhibit Anti-Atherogenic Properties
- (2018) Nobuaki Tanaka et al. CIRCULATION JOURNAL
- Heme oxygenase-1 deficiency promotes severity of sepsis in a non-surgical preterm mouse model
- (2018) Kazumichi Fujioka et al. PEDIATRIC RESEARCH
- Activation of Invariant Natural Killer T Cells Redirects the Inflammatory Response in Neonatal Sepsis
- (2018) Alexandra C. Bolognese et al. Frontiers in Immunology
- Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation
- (2018) Paul C. Norris et al. Scientific Reports
- Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury
- (2017) Ronald Carnemolla et al. FASEB JOURNAL
- Late Therapeutic Intervention with Antibiotics and Fluid Resuscitation Allows for a Prolonged Disease Course with High Survival in a Severe Murine Model of Sepsis
- (2017) Allison M. Steele et al. SHOCK
- Induction of Heme Oxygenase-1 Attenuates the Severity of Sepsis in a Non-Surgical Preterm Mouse Model
- (2017) Kazumichi Fujioka et al. SHOCK
- Evaluation of the effect of recombinant thrombomodulin on a lipopolysaccharide-induced murine sepsis model
- (2017) Kazuhiro Takehara et al. Experimental and Therapeutic Medicine
- Cross Talk Pathways Between Coagulation and Inflammation
- (2016) Jonathan H. Foley et al. CIRCULATION RESEARCH
- Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis
- (2015) K. Yamakawa et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Sepsis: a roadmap for future research
- (2015) Jonathan Cohen et al. LANCET INFECTIOUS DISEASES
- Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue
- (2014) Romain A. Colas et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
- (2014) Christopher D. Buckley et al. IMMUNITY
- A New Cecal Slurry Preparation Protocol with Improved Long-Term Reproducibility for Animal Models of Sepsis
- (2014) Marlene E. Starr et al. PLoS One
- Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study
- (2014) Guoping Zheng et al. RESPIRATORY RESEARCH
- Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation
- (2013) Akira Shirahata et al. EUROPEAN JOURNAL OF PEDIATRICS
- Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
- (2013) Kazuma Yamakawa et al. INTENSIVE CARE MEDICINE
- Effect of thrombomodulin on the development of monocrotaline-induced pulmonary hypertension
- (2013) Yasuharu Yamada et al. Journal of Anesthesia
- Pancreatic Digestive Enzyme Blockade in the Intestine Increases Survival After Experimental Shock
- (2013) F. A. DeLano et al. Science Translational Medicine
- Animal models of sepsis
- (2013) Mitchell P Fink Virulence
- Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis
- (2012) S. Zaitsev et al. BLOOD
- Current trends in inflammatory and immunomodulatory mediators in sepsis
- (2012) M. Aziz et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Infection regulates pro-resolving mediators that lower antibiotic requirements
- (2012) Nan Chiang et al. NATURE
- Thrombomodulin: protectorate God of the vasculature in thrombosis and inflammation
- (2011) T. ITO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?
- (2011) Lien Dejager et al. TRENDS IN MICROBIOLOGY
- Novel Lipid Mediators and Resolution Mechanisms in Acute Inflammation
- (2010) Charles N. Serhan AMERICAN JOURNAL OF PATHOLOGY
- Pathophysiology and Treatment of Septic Shock in Neonates
- (2010) James L. Wynn et al. CLINICS IN PERINATOLOGY
- Anchoring Fusion Thrombomodulin to the Endothelial Lumen Protects against Injury-induced Lung Thrombosis and Inflammation
- (2009) Bi-Sen Ding et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia
- (2009) Masaru Nagato et al. CRITICAL CARE MEDICINE
- Immunotherapy in neonatal sepsis: advances in treatment and prophylaxis
- (2009) Michael Cohen-Wolkowiez et al. CURRENT OPINION IN PEDIATRICS
- Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
- (2009) Matthew Spite et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More